Ad. Levy et al., MONOAMINERGIC REGULATION OF NEUROENDOCRINE FUNCTION AND ITS MODIFICATION BY COCAINE, Frontiers in neuroendocrinology, 15(2), 1994, pp. 85-156
Neuroendocrine pharmacology represents a potentially valuable approach
to the assessment of alterations in neuronal function in the brain of
human cocaine abusers. Neuroendocrine effects of the monoamine uptake
inhibitor cocaine have predominantly been examined in laboratory anim
als. These preclinical studies may help to identify the optimal challe
nge tests to be performed in clinical studies. In laboratory animals,
acute administration of cocaine activates the hypothalamic-pituitary-a
drenal axis, via actions on serotonergic and dopaminergic neurons in t
he brain. Cocaine also reduces prolactin secretion, probably by dopami
nergic mechanisms, although the necessary studies to confirm this hypo
thesis have not been performed. Cocaine also reduces renin secretion,
and increases vasopressin and luteinizing hormone secretion, by mechan
isms which have not been clearly established. The adrenocorticotropin,
corticosterone, prolactin, and renin responses to cocaine are general
ly unaltered by prior cocaine exposure, suggesting that tolerance or s
ensitization to the endocrine effects of cocaine does not occur. Howev
er, several studies have determined that prior cocaine exposure alters
the serotonergic regulation of hormone secretion. Chronic cocaine exp
osure reduces some of the hormone responses to the serotonin (5-HT) re
leasers p-chloroamphetamine and d-fenfluramine, suggesting deficits in
the functional status of serotonergic nerve terminals. Additionally,
repeated cocaine exposure produces subsensitive 5-HT1A-mediated hormon
e responses, and supersensitive 5-HT2-mediated responses. Alterations
in dopaminergic- or noradrenergic-mediated hormone responses have not
been examined in animals chronically exposed to cocaine. Endocrine stu
dies in human cocaine abusers have largely examined basal hormone leve
ls or the hormone responses to cocaine. Strong conclusions from these
studies are limited because (1) many neuronal and nonneuronal systems
regulate secretion of each hormone, so that alterations in basal hormo
ne levels cannot be attributed to only one neurotransmitter; and (2) h
ormone responses to cocaine cannot he examined in cocaine-naive subjec
ts due to ethical considerations, making it impossible to determine wh
ether the response in cocaine abusers is abnormal. It may be more bene
ficial for studies in cocaine abusers to examine the hormone responses
to drugs that specifically affect monoaminergic neurons and compare t
he data with cocaine-naive individuals. (C) 1994 Academic Press, Inc.